An Indonesian pharmaceutical firm has postponed a plan to sell a Chinese Covid-19 vaccine directly to the public amid criticism by health experts that such commercial schemes could bypass vulnerable groups in a country that promised free shots to all.

The decision came as coronavirus cases and deaths from the virus have hit record highs, pushing the healthcare system close to breaking point in parts of densely populated Java island.

State-owned pharmaceutical company Kimia Farma said...